Contract service providers must step up their game to stay competitive in increasingly complex bio/pharma market.

Pharmaceutical Outsourcing Present and Future

The need for preclinical testing expertise is growing as molecular complexity increases.

Navigating the Preclinical CRO Outsourcing Process

A look at the newest innovations offers a deeper understanding of affinity ligands and their role in the future of downstream processing.

A Closer Look at Affinity Ligands

Topic

Siegfried Schmitt, PhD, is Vice President Technical at Parexel International, Siegfried.Schmitt@parexel.com.

Articles

Siegfried Schmitt, principal consultant at PAREXEL, discusses the state of drug manufacturing in India.

Drug Manufacturing Focus: Why India?

Jim Miller is president of PharmSource Information Services, Inc., and publisher of Bio/Pharmaceutical Outsourcing Report.

Ongoing changes create new opportunities for CROs and CMOs.

Climate Change in Outsourcing

Brian Galliher of Cook Pharmica discusses visual inspection systems.

Q&A with Brian Galliher, Cook Pharmica

Eric Langer has over 25 years experience in biotechnology and life sciences strategic marketing management, market research, and publishing. He has held senior management and marketing positions at biopharmaceutical supply companies. He has published and authored many books and reports on topics in Biotechnology, Large-scale BioManufacturing, and bioscience commercialization and communication. He teaches at Johns Hopkins University marketing management, biotech marketing, services marketing, and marketing in a regulated environment. In 1989 he co-founded BioPlan Associates, Inc. to provide market analysis, and strategy to biotech and healthcare organizations.

Data from BioPlan Associates’ 10th Annual Report and Survey of Biopharmaceutical Manufacturing Capacity and Production suggest that the interest in disposable devices has begun to extend to biopharma operations beyond basic single-use bags and connectors.

Disposable Applications in Demand by Biopharma

Recipharm has invested EUR 32 million ($43 million) in its Wasserburg, Germany site to expand lyophilization capacity.

Recipham to Expand Lyophilization Capacity in Germany

Practicality of implementation should be a part of vision in the bio/pharmaceutical industry.

The Expense of Vision in Outsourcing

Anthony DeStefano, PhD, is 2013 president of the American Association of Pharmaceutical Scientists (AAPS).

Through its educational and networking opportunities, the American Association of Pharmaceutical Scientists plays an important role in partnering throughout the drug- development and commercialization process.

Changing the Dynamic of CROs

New partnership aims to eliminate months from the typical transition time required to move chemistry from the laboratory into commercial applications.

Sigma-Aldrich, The Scripps Research Institute Translating Research into Commercial Applications

Ronald A. Rader is senior director, Technical Research, at BioPlan Associates.

Advances in techniques and single-use systems are revolutionizing vaccine manufacturing.

Bioprocessing Advances in Vaccine Manufacture

Patricia Van Arnum was executive editor of Pharmaceutical Technology.

A recent survey shows that talent retention is an issue on industry level for contract research organizations (CROs), particularly for CROs located outside the United States.